Outcome taxonomy | |
 1. Mortality | |
 2. 2–24: Physiological/clinical | |
 2: Blood and lymphatic system outcomes | |
 3: Cardiac outcomes | |
 4: Congenital, familial and genetic outcomes | |
 5: Endocrine outcomes | |
 6: Ear and labyrinth outcomes | |
 7: Eye outcomes | |
 8: Gastrointestinal outcomes | |
 9: General outcomes | |
 10: Hepatobiliary outcomes | |
 11: Immune system outcomes | |
 12: Infection and infestation outcomes | |
 13: Injury and poisoning outcomes | |
 14: Metabolism and nutrition outcomes | |
 15: Musculoskeletal and connective tissue outcomes | |
 16: Outcomes relating to neoplasms: benign, malignant and unspecified | |
 17: Nervous system outcomes | |
 18: Pregnancy, puerperium and perinatal outcomes  19: Renal and urinary outcomes | |
 20: Reproductive system and breast outcomes | |
 21: Psychiatric outcomes | |
 22: Respiratory, thoracic and mediastinal outcomes | |
 23: Skin and subcutaneous tissue outcomes | |
 24: Vascular outcomes | |
Functioning | |
 25: Physical functioning | |
 26: Social functioning | |
 27: Role functioning | |
 28: Emotional functioning/well-being | |
 29: Cognitive functioning | |
 31: Perceived health status | |
 32: Delivery of care, including; | |
  - Satisfaction/patient preference | |
  - Acceptability and availability | |
  - Adherence/compliance | |
  - Withdrawal from treatment | |
  - Appropriateness of treatment | |
  - Process, implementation, and service outcomes | |
 33: Personal circumstances | |
Resource use | |
 34: Economic | |
 35: Hospital | |
 36: Need for further intervention | |
 37: Societal/carer burden | |
 38: Adverse events/effects |